Cargando…

Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome

BACKGROUND AND PURPOSE: Opioids may inhibit the 5‐HT transporter (SERT) and the noradrenaline transporter (NET). NET inhibition may contribute to analgesia, and SERT inhibition or interactions with 5‐HT receptors may cause serotonergic toxicity. However, the effects of different opioids on the human...

Descripción completa

Detalles Bibliográficos
Autores principales: Rickli, Anna, Liakoni, Evangelia, Hoener, Marius C, Liechti, Matthias E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773950/
https://www.ncbi.nlm.nih.gov/pubmed/29210063
http://dx.doi.org/10.1111/bph.14105
_version_ 1783293671000506368
author Rickli, Anna
Liakoni, Evangelia
Hoener, Marius C
Liechti, Matthias E
author_facet Rickli, Anna
Liakoni, Evangelia
Hoener, Marius C
Liechti, Matthias E
author_sort Rickli, Anna
collection PubMed
description BACKGROUND AND PURPOSE: Opioids may inhibit the 5‐HT transporter (SERT) and the noradrenaline transporter (NET). NET inhibition may contribute to analgesia, and SERT inhibition or interactions with 5‐HT receptors may cause serotonergic toxicity. However, the effects of different opioids on the human SERT, NET and 5‐HT receptors have not been sufficiently studied. EXPERIMENTAL APPROACH: We determined the potencies of different opioids to inhibit the SERT and NET in vitro using human transporter‐transfected HEK293 cells. We also tested binding affinities at 5‐HT(1A), 5‐HT(2A) and 5‐HT(2C) receptors. Additionally, we assessed clinical cases of the serotonin syndrome associated with each opioid reported by PubMed and a World Health Organization database. KEY RESULTS: Dextromethorphan, l(R)‐methadone, racemic methadone, pethidine, tramadol and tapentadol inhibited the SERT at or close to observed drug plasma or estimated brain concentrations in patients. Tapentadol was the most potent NET inhibitor. Pethidine, tramadol, l(R)‐methadone, racemic methadone, dextromethorphan and O‐desmethyltramadol also inhibited the NET. 6‐Monoacetylmorphine, buprenorphine, codeine, dihydrocodeine, heroin, hydrocodone, hydromorphone, morphine, oxycodone and oxymorphone did not inhibit the SERT or NET. Fentanyl interacted with 5‐HT(1A) receptors and methadone, pethidine and fentanyl with 5‐HT(2A) receptors, in the low micromolar range. Opioids most frequently associated with the serotonin syndrome are tramadol, fentanyl, tapentadol, oxycodone, methadone and dextromethorphan. CONCLUSIONS AND IMPLICATIONS: Some synthetic opioids interact with the SERT and NET at potentially clinically relevant concentrations. SERT inhibition by tramadol, tapentadol, methadone, dextromethorphan and pethidine may contribute to the serotonin syndrome. Direct effects on 5‐HT(1A) and/or 5‐HT(2A) receptors could be involved with methadone and pethidine.
format Online
Article
Text
id pubmed-5773950
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57739502018-01-31 Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome Rickli, Anna Liakoni, Evangelia Hoener, Marius C Liechti, Matthias E Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: Opioids may inhibit the 5‐HT transporter (SERT) and the noradrenaline transporter (NET). NET inhibition may contribute to analgesia, and SERT inhibition or interactions with 5‐HT receptors may cause serotonergic toxicity. However, the effects of different opioids on the human SERT, NET and 5‐HT receptors have not been sufficiently studied. EXPERIMENTAL APPROACH: We determined the potencies of different opioids to inhibit the SERT and NET in vitro using human transporter‐transfected HEK293 cells. We also tested binding affinities at 5‐HT(1A), 5‐HT(2A) and 5‐HT(2C) receptors. Additionally, we assessed clinical cases of the serotonin syndrome associated with each opioid reported by PubMed and a World Health Organization database. KEY RESULTS: Dextromethorphan, l(R)‐methadone, racemic methadone, pethidine, tramadol and tapentadol inhibited the SERT at or close to observed drug plasma or estimated brain concentrations in patients. Tapentadol was the most potent NET inhibitor. Pethidine, tramadol, l(R)‐methadone, racemic methadone, dextromethorphan and O‐desmethyltramadol also inhibited the NET. 6‐Monoacetylmorphine, buprenorphine, codeine, dihydrocodeine, heroin, hydrocodone, hydromorphone, morphine, oxycodone and oxymorphone did not inhibit the SERT or NET. Fentanyl interacted with 5‐HT(1A) receptors and methadone, pethidine and fentanyl with 5‐HT(2A) receptors, in the low micromolar range. Opioids most frequently associated with the serotonin syndrome are tramadol, fentanyl, tapentadol, oxycodone, methadone and dextromethorphan. CONCLUSIONS AND IMPLICATIONS: Some synthetic opioids interact with the SERT and NET at potentially clinically relevant concentrations. SERT inhibition by tramadol, tapentadol, methadone, dextromethorphan and pethidine may contribute to the serotonin syndrome. Direct effects on 5‐HT(1A) and/or 5‐HT(2A) receptors could be involved with methadone and pethidine. John Wiley and Sons Inc. 2018-01-06 2018-02 /pmc/articles/PMC5773950/ /pubmed/29210063 http://dx.doi.org/10.1111/bph.14105 Text en © 2017 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Papers
Rickli, Anna
Liakoni, Evangelia
Hoener, Marius C
Liechti, Matthias E
Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title_full Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title_fullStr Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title_full_unstemmed Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title_short Opioid‐induced inhibition of the human 5‐HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
title_sort opioid‐induced inhibition of the human 5‐ht and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773950/
https://www.ncbi.nlm.nih.gov/pubmed/29210063
http://dx.doi.org/10.1111/bph.14105
work_keys_str_mv AT ricklianna opioidinducedinhibitionofthehuman5htandnoradrenalinetransportersinvitrolinktoclinicalreportsofserotoninsyndrome
AT liakonievangelia opioidinducedinhibitionofthehuman5htandnoradrenalinetransportersinvitrolinktoclinicalreportsofserotoninsyndrome
AT hoenermariusc opioidinducedinhibitionofthehuman5htandnoradrenalinetransportersinvitrolinktoclinicalreportsofserotoninsyndrome
AT liechtimatthiase opioidinducedinhibitionofthehuman5htandnoradrenalinetransportersinvitrolinktoclinicalreportsofserotoninsyndrome